BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 700911)

  • 1. Pharmacokinetics of chlordiazepoxide and metabolites following single and multiple oral doses.
    Greenblatt DJ; Shader RI; Franke K; Harmatz JS
    Int J Clin Pharmacol Biopharm; 1978 Oct; 16(10):486-93. PubMed ID: 700911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of plasma levels of chlordiazepoxide and metabolites to clinical response.
    Lin KM; Friedel RO
    Am J Psychiatry; 1979 Jan; 136(1):18-23. PubMed ID: 364999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First dose and steady state pharmacokinetics of nimesulide and its 4-hydroxy metabolite in healthy volunteers.
    Gandini R; Montalto C; Castoldi D; Monzani V; Nava ML; Scaricabarozzi I; Vargiu G; Bartosek I
    Farmaco; 1991 Sep; 46(9):1071-9. PubMed ID: 1807292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of oral intramuscular chlordiazepoxide by alcoholics.
    Perry PJ; Wilding DC; Fowler RC; Hepler CD; Caputo JF
    Clin Pharmacol Ther; 1978 May; 23(5):535-41. PubMed ID: 639427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of clofazimine in healthy volunteers.
    Schaad-Lanyi Z; Dieterle W; Dubois JP; Theobald W; Vischer W
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):9-15. PubMed ID: 3559339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absorption of intramuscular chlordiazepoxide (Librium) in patients with severe alcoholic liver disease.
    Robinson JD; Whitney HA; Guisti DL; Morgan DD; Mendenhall CL
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):433-8. PubMed ID: 6629548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability, QTc evaluation, and pharmacokinetics of single and multiple doses of enzastaurin HCl (LY317615), a protein kinase C-beta inhibitor, in healthy subjects.
    Welch PA; Sinha VP; Cleverly AL; Darstein C; Flanagan SD; Musib LC
    J Clin Pharmacol; 2007 Sep; 47(9):1138-51. PubMed ID: 17766700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of chlordiazepoxide.
    Greenblatt DJ; Shader RI; MacLeod SM; Sellers EM
    Clin Pharmacokinet; 1978; 3(5):381-94. PubMed ID: 359214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
    Furr M; Kennedy T
    Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
    Smith RB; Gwilt PR; Wright CE
    Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and relative potency assays with analgesic medications.
    Gruber CM
    J Med; 1983; 14(3):203-10. PubMed ID: 6580370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
    Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption rate, blood concentrations, and early response to oral chlordiazepoxide.
    Greenblatt DJ; Shader RI; Harmatz JS; Franke K; Koch-Weser J
    Am J Psychiatry; 1977 May; 134(5):559-62. PubMed ID: 848586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
    Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
    Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing blood concentrations of chlordiazepoxide: a use of multiple regression analysis.
    Greenblatt DJ; Harmatz JS; Stanski DR; Shader RI; Franke K; Koch-Weser J
    Psychopharmacology (Berl); 1977 Nov; 54(3):277-82. PubMed ID: 413145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients.
    Stanski DR; Greenblatt DJ; Selwyn A; Shader RI; Franke K; Koch-Weser J
    Clin Pharmacol Ther; 1976 Nov; 20(5):571-8. PubMed ID: 975729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.